Skip to main content

Table 3 Number of miRNAs differentially expressed in RNA sequencing validated by FirePlexa

From: Evaluation of commercially available small RNASeq library preparation kits using low input RNA

Kit

Tissue Comparison

Differentially Expressed miRNAs (RNASeq)a

Assayed by FirePlex

Concordant – in same direction as RNASeq (%)

Discordant – in opposite direction as RNASeq (%)

Concordant and Significant (%)

BiooScientific

B_vs_L

322

47

39 (82.98%)

8 (17.02%)

28 (59.57%)

BiooScientific

B_vs_P

366

54

52 (96.3%)

2 (3.7%)

35 (64.81%)

BiooScientific

P_vs_L

317

42

41 (97.62%)

1 (2.38%)

32 (76.19%)

Illumina-TruSeq

B_vs_L

227

43

39 (90.7%)

4 (9.3%)

29 (67.44%)

Illumina-TruSeq

B_vs_P

295

53

50 (94.34%)

3 (5.66%)

35 (66.04%)

Illumina-TruSeq

P_vs_L

241

38

38 (100%)

0 (0%)

31 (81.58%)

NEB

B_vs_L

250

45

39 (86.67%)

6 (13.33%)

29 (64.44%)

NEB

B_vs_P

312

51

50 (98.04%)

1 (1.96%)

34 (66.67%)

NEB

P_vs_L

262

39

39 (100%)

0 (0%)

31 (79.49%)

  1. The differentially expressed miRNAs in RNA sequencing have an average expression (calculated across both tissues denoted in the “Tissue comparison” column) ≥ 50 counts and is expressed in at least 25% of the total number of replicates for each pairwise comparison. The percentage of concordant and discordant miRNAs are calculated based on the number of miRNAs assayed by FirePlex. Significant miRNAs in FirePlex: p < 0.05